drugset / Trial / NCT01943552

Ipratropium Bromide in Peri-Operative COPD

NCT01943552

Phase 4 Completed 192 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled, parallel-group, multi-centre trial.The trial aims to evaluate efficacy of nebulized ipratropium bromide in Chinese peri-operative patients with COPD under general anaesthesia.

Timeline

Start
2013-10
Primary completion
2015-07
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ipratropium Small molecule 500 ug Other